New data by AKL Therapeutics suggests investigational oral osteoarthritis drug APPA may have a promising senotherapeutic effect with potential in other diseases of ageing : vimarsana.com

New data by AKL Therapeutics suggests investigational oral osteoarthritis drug APPA may have a promising senotherapeutic effect with potential in other diseases of ageing

/PRNewswire/ -- New data* presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in Denver, Colorado (March 17th-20th)...

Related Keywords

United Kingdom , Stevenage , Hertfordshire , Spain , Denver , Colorado , United States , London , City Of , Alan Reynolds , David Miles , Linda Rose , Chondrogiannin Senolytics , World Congress , Osteoarthritis Research Society International , Regulatory Agency , Institute Of Biomedical Research , Research Society International , Biomedical Research , Chief Scientific Officer , Chronic Obstructive Pulmonary Disease , Chief Executive Officer , Innovation Passport , Stevenage Bioscience Catalyst , Herts United , Radic Biol , Manag Healthc , Academic Press , Aging Drug , Based Complement Alternat , Site Specific Osteoarthritis From , Findings From , Global Burden , Disease Study , Akl Therapeutics ,